InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: J-Belfort post# 7531

Sunday, 08/16/2020 7:28:35 AM

Sunday, August 16, 2020 7:28:35 AM

Post# of 44690
This is a crazy company - read the interview with chairman. Clearly a gambling stock.
@ $1 - the market cap will be $2 B +
CEO clearly says dilution for trials - he will have dilute crazily and then carry reverse split.
NeuroRx is a partner and is conducting trials.

Co market cap - $ 1.13 B
April Price - 3.8 cents Today - 54 cents
- Co does not have an approved product
- co is conducting trial for Covid
- co had cash of $137,000 at the start of the year
- Co does not have a CEO
- co is run by Chairman (Ram Sevalaraju) who is biotech analyst with HC Weightworth
- co needs at least $20 million to run the trials and do not have any money
- if approved they talk about making $100-200 million sales

https://themarket.ch/interview/relief-therapeutics-our-drug-could-generate-hundreds-of-millions-of-dollars-per-year-ld.2478